---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-25-002245"
form_type: "8-K"
ticker: "SBFM"
cik: "0001402328"
company_name: "Sunshine Biopharma Inc."
filed_at: "2025-04-03T23:59:59+00:00"
generated_at: "2026-05-23T22:23:34.005343+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Sunshine Biopharma closes $2.46M registered direct offering of common stock and pre-funded warrants

## Summary
- Gross proceeds of approximately $2.46M from sale of 1,188,404 shares of common stock (or pre-funded warrants) at $2.07 per share.
- Net proceeds of approximately $1.8M after deducting offering expenses; funds to be used for general corporate purposes and working capital.
- Pre-funded warrants exercisable immediately at $0.001 per share; expire when exercised in full.
- Offering closed on April 3, 2025; Aegis Capital acted as exclusive placement agent.
- Pricing was at the market under Nasdaq rules; shelf registration statement effective January 15, 2025.

## SEC filing metadata
- accession: 0001683168-25-002245
- form_type: 8-K
- ticker: SBFM
- cik: 0001402328
- company_name: Sunshine Biopharma Inc.
- filed_at: 2025-04-03T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1402328/000168316825002245/0001683168-25-002245-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1402328/000168316825002245/sunshine_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-25-002245
- JSON: https://secwatch.observer/filing/0001683168-25-002245.json
- Plain text: https://secwatch.observer/filing/0001683168-25-002245.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.